| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 37 |
| 1 | CISPLATIN | 36 |
| 2 | BLEOMYCIN | 32 |
| 3 | BLEOMYCIN SULFATE | 32 |
| 4 | ADALIMUMAB | 5 |
| 5 | CARBOPLATIN | 5 |
| 6 | CYCLOPHOSPHAMIDE | 5 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 5 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 5 |
| 9 | IFOSFAMIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLEOMYCIN SULFATE | 32 | 0.0031 |
| 1 | ESTROGEN | 2 | 0.0007 |
| 2 | APOMORPHINE HYDROCHLORIDE | 1 | 0.0006 |
| 3 | ETOPOSIDE | 37 | 0.0005 |
| 4 | CISPLATIN | 36 | 0.0005 |
| 5 | GOLIMUMAB | 3 | 0.0002 |
| 6 | IFOSFAMIDE FOR INJECTION | 5 | 0.0002 |
| 7 | ELOSULFASE ALFA | 1 | 0.0002 |
| 8 | BENZOYL PEROXIDE | 1 | 0.0001 |
| 9 | HUMAN IMMUNOGLOBULIN G | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 38 |
| 1 | Topoisomerase Inhibitor [EPC] | 37 |
| 2 | Alkylating Drug [EPC] | 10 |
| 3 | Corticosteroid [EPC] | 7 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 5 |
| 5 | Integrin Receptor Antagonist [EPC] | 4 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 7 | Human Immunoglobulin G [EPC] | 3 |
| 8 | Benzodiazepine [EPC] | 2 |
| 9 | Estrogen [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 37 | 0.0005 |
| 1 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 38 | 0.0001 |
| 3 | Typical Antipsychotic [EPC] | 2 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 4 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 10 | 0.0000 |
| 8 | Iron Chelator [EPC] | 1 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |